Belite Bio, Inc. Sponsored ADR (BLTE) vs Scholar Rock Holding Corporation (SRRK)

Belite Bio, Inc. Sponsored ADR and Scholar Rock Holding Corporation are both Biotechnology companies. Belite Bio, Inc. Sponsored ADR is the larger, with a market value of $6.8B against $6.0B — 1.1× the size. Across the 10 metrics below, Belite Bio, Inc. Sponsored ADR leads on 7 and Scholar Rock Holding Corporation on 3.

Valuation

Metric BLTE SRRK Biotechnology median
P/E n/m n/m 7.88
P/S n/m 134.64 11.47
P/B 8.73 25.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 128.39 10.73
Earnings yield (1.63%) (7.08%) (28.84%)
Free cash flow yield (0.99%) (4.66%) (23.03%)

Profitability

Metric BLTE SRRK Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (167.77%) (57.72%)
Return on assets (21.60%) (94.63%) (49.22%)
Return on invested capital (9.55%) 0.00% 0.00%

Growth

Metric BLTE SRRK Biotechnology median
Revenue growth (TTM) — 213.65% 5.64%
EPS growth (last fiscal year) (95.76%) (33.20%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE SRRK Biotechnology median
Debt to equity 0.00 0.77 0.00
Current ratio 33.56 7.02 4.73
Net debt to EBITDA 5.88 0.69 0.96

Dividend

Metric BLTE SRRK Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric BLTE SRRK Biotechnology median
Market cap 6.82b 5.96b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack